Semaglutide mimics GLP-1 hormone released by gut after eating, which attaches itself to GLP-1 receptors in the body. Activated receptors help reduce blood sugar and curb appetite.
Despite our greatest aspirations for quick fixes, it’s very possible that a healthy lifestyle remains the most important way to manage metabolic disease and overall health.
In clinical trials, tirzepatide by Eli Lilly has shown to reduce body weight by up to 22.5 percent, on average, after about 72 weeks, according to the company.
Obesity drugs like Ozempic have been global smash-hits, but loss of muscle mass along with fat is a worry. Now, a promising new drug called HS235 has got doctors excited.
Weight gain is a severe problem because it can lead to serious complications such as high blood pressure, heart problems, and a variety of other health problems.
Novo Nordisk says results of its trials show a 2.4 mg dose can cut down major heart-related ailments by 20%, and the study will be published in a peer-reviewed journal by end of year.
Patients who got a weekly injection of the experimental anti-obesity drug retatrutide lost up to 24 per cent of their body weight in 48 weeks, show phase-2 trials published this week.
BJP’s fate in the second phase of 2024 Lok Sabha election will be decided in Karnataka, Rajasthan, and Maharashtra, where it performed very well in 2019 but faces a stiff competition now.
The private lender's shares tumbled to be top Nifty 50 loser after India's central bank barred it from taking on new customers through online and mobile banking channels.
Another addition to military cooperation has been the Strategic Space Dialogue, inaugurated in Paris in 2023. Last month, India participated as an observer to France’s AsterX.
COMMENTS